Application wogonin for preparing medicine to treat leukaemia

A technology of wogonin and leukemia, which is applied in the field of application of wogonin in the preparation of medicines for treating leukemia, and achieves the effect of being beneficial to clinical application and having little toxic effect

Active Publication Date: 2006-06-14
CHINA PHARM UNIV +1
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] However, the application of wogonin in the preparation of drugs for the treatment of leukemia, especially the research on the pr

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application wogonin for preparing medicine to treat leukaemia
  • Application wogonin for preparing medicine to treat leukaemia
  • Application wogonin for preparing medicine to treat leukaemia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] Take 10g of wogonin, add appropriate auxiliary materials for injections (including freeze-dried powder injections and sterile subpackaged dry powder injections), and prepare anti-leukemia drug injections according to the injection (including freeze-dried powder injections and sterile subpackaged dry powder injections) process.

Embodiment 2

[0068] Take wogonin 10g, add suitable auxiliary materials for tablets (including sustained and controlled release tablets, matrix tablets, coated tablets, dispersible tablets, etc.), press the tablet (including sustained and controlled release tablets, matrix tablets, coated tablets, dispersible tablets, etc.) ) technology is prepared into anti-leukemia tablet.

Embodiment 3

[0070] Take 10 g of wogonin, add appropriate auxiliary materials for capsules, and prepare anti-leukemia drug capsules according to the capsule process.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An application of wogonin in preparing the medicines for treating particular-type leukemia by inducing the differentiation of leukemia cells to particle system is disclosed.

Description

technical field [0001] The invention belongs to the field of pharmacy and relates to the application of wogonin in the preparation of medicines for treating leukemia. Background technique [0002] Leukemia is a malignant disease that originates from the hematopoietic system and is characterized by the production and accumulation of a large number of immature and abnormal white blood cells in the bone marrow or other hematopoietic tissues. From the perspective of form, most leukemia cells are immature and abnormally morphological white blood cells; in terms of function, leukemia cells have the same characteristics as tumor cells: leukemia cells proliferate in a tumorous manner, which cannot be controlled, often leading to the inhibition and failure of bone marrow hematopoietic function. It can cause anemia, neutropenia and thrombocytopenia in patients. Leukemic cells can infiltrate various tissues and organs throughout the body, and damage the functions of various organs, suc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/352A61P35/00
Inventor 郭青龙张坤俞军尤启冬王伟张海伟顾红燕赵丽胡扬
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap